Three-Person DNA IVF Prevents Inherited Disease: Eight Healthy Babies Born in UK First
Published: July 23, 2025
Source: ICAEPA News Desk | Based on research from Newcastle University & The New England Journal of Medicine
In a revolutionary advancement in assisted reproduction, scientists in the United Kingdom have successfully delivered eight healthy babies using DNA from three individuals. This milestone was achieved through a pioneering IVF technique designed to eliminate inherited mitochondrial diseases, offering new hope to families facing genetic risks.
Understanding Mitochondrial Disease
Mitochondria, often called the “powerhouses” of cells, generate energy essential for life. Unlike nuclear DNA, mitochondrial DNA (mtDNA) is inherited exclusively from the mother. Harmful mutations in mtDNA can result in incurable conditions affecting the brain, heart, and muscles.
These diseases affect around 1 in every 5,000 children. Currently, there is no cure, but the new IVF method, called mitochondrial donation, aims to prevent these mutations from being passed down to future generations.
What Is Three-Person IVF and Pronuclear Transfer?
The procedure used is known as pronuclear transfer (PNT), a technique performed after fertilization. Here’s how it works:
- The mother’s egg is fertilized with the father’s sperm.
- The resulting nuclear DNA is extracted.
- This DNA is inserted into a healthy donor egg that has had its nuclear DNA removed.
- The embryo created has nuclear DNA from the parents and healthy mitochondria from the donor.
This results in a child with genetic traits from both parents, and healthy mitochondrial DNA from a third individual, effectively preventing the mitochondrial disease from being passed on.
Clinical Success and Follow-up
The eight babies born—four boys and four girls including identical twins—are healthy and developing normally. All babies are currently enrolled in a long-term follow-up study. Tests revealed:
- No detectable mitochondrial mutations in five babies.
- Very low levels (5% to 20%) of mutated mtDNA in three others—well below disease-causing levels (80%).
Minor health issues, including a urinary infection and a brief irregular heartbeat in one child, were treated successfully and are not linked to the IVF procedure.
Parents and Scientists Share Their Hope
One mother expressed her gratitude, saying:
“As parents, all we ever wanted was to give our child a healthy start in life. Mitochondrial donation IVF made that possible.”
Professor Mary Herbert, lead researcher, stated:
“Our findings give grounds for optimism. Ongoing research will continue to improve this life-changing treatment.”
Legal and Ethical Considerations
The UK was the first country in the world to legalize mitochondrial donation in 2015 under the Human Fertilisation and Embryology Authority (HFEA). The treatment is currently offered in the UK as part of the NHS Mitochondrial Reproductive Care Pathway, following strict clinical and ethical guidelines.
Australia has also passed similar legislation, and global discussions are ongoing.
Conclusion: A New Dawn for Reproductive Medicine
This breakthrough in three-person IVF signals a transformative shift in how we approach inherited diseases. With ongoing monitoring and regulation, mitochondrial donation technology could help thousands of families break free from genetic cycles of disease.
References
- Newcastle University (2025). “Mitochondrial Donation in a Reproductive Care Pathway for mtDNA Disease.” The New England Journal of Medicine.
- ScienceDaily (2025). “Three-Person DNA IVF Stops Inherited Disease—Eight Healthy Babies Born in UK First.”